Because it upregulates several tumor suppressor genes, EGR1 is also considered to be a tumor suppressor, and lower EGR1 expression has been associated with poorer outcomes in many cancer types, including non-small-cell lung cancer, osteosarcoma, glioma and breast cancer [39–42]. The gene discussed is EGR1; the disease is osteosarcoma.